|
in-trim advantage
give your body the edge it deserves! |
Bodybuilding Fitness Health Weight Loss |
Muscletech |
![]() |
CREAKIC Has an ability to neutralize ROS (reactive oxgen species) allowing bodybuilders to maximize their muscle and strength building potential. Optimal cellular environment for muscle creatine absorption and muscle cell repair Revolutionary creatine technol |
CREAKIC represents the culmination of many years of research into identifying and solving the one critical problem every regular creatine pill has failed to address – Reactive Oxygen Species (ROS). Elevated levels of ROS in the muscle cells short-circuit the creatine transport process to the extent that, collectively, they can limit creatine uptake by your muscles. No other creatine pill to date has been engineered to scavenge ROS and combat their negative effects on your muscle growth. However, thanks to the Team MuscleTech multimillion dollar research budget and the medical doctor-led Team MuscleTech research group, CREAKIC is the world’s first and only muscle creatine receptor hyperactivator formulated to deliver greater muscle growth by attacking and neutralizing ROS. This diactivation creates an optimal cellular environment for muscle creatine absorption and muscle cell repair, helping you to make explosive gains in muscle and strength with weight training.
Label Information CREAKIC (Creatine-6-8-thioctic acid-ketoisocaproic acid calcium), Microcrystalline Cellulose, Hydroxpropyl Cellulose, Polyvinylpyrrolidone, Croscarmellose Sodium, Calcium Carbonate, Vegetable Stearine, Magnesium Stearate, Magnesium Silicate, Silica, Coating FD&C Blue No.2, Polyethylene Glycol, Polyvinyl Alcohol, Talc, Titanium Dioxide, Sodium Chloride, Sodium Glycolate Usage As a dietary supplement, take 2 servings each serving consisting of 3 caplets with an 8oz glass of water daily. On workout days, take 1 serving in the morning and the other immediately after your workout. On non workout days, take 1 serving in the morning and the other anytime during the day. |
|